Cel-scI.com
About Cel-scI.com
CEL-SCI is dedicated to improving the treatment of cancer and other diseases by unleashing the power of the immune system; the body's natural and most potent defense system. Our flagship product, Multikine®, is the first immunotherapeutic agent being developed as a first-line standard of care treatment for cancer. Multikine® is the first of a new class of cancer immunotherapy drugs called Immune SIMULATORs.
